In our study, we evaluated a large sample of 591 histologically diagnosed glioblastoma patients with homogenous clinical and molecular characteristics (ECOG PS 0–2, IDH1-2 wild-type treated with standard chemoradiotherapy). Here, IDH1 is linked to glioblastoma.